Current filters:


Popular Filters

6576 to 6600 of 6944 results

US investment in health research remains stagnant, new research shows


In 2010, the US public and private sectors invested $140.5 billion in 2010 on research to find new ways…

FinancialNorth AmericaPharmaceuticalResearch

USA’s Affordable Care Act delivers lower costs to more seniors with Medicare, new data shows


Quoting new data, the US Centers for Medicare & Medicaid Services (CMS) says that more seniors and people…

FinancialHealthcareNorth AmericaPharmaceutical

Vast majority of surveyed European physicians see need for ultra-fast insulins


The vast majority of surveyed physicians in the EU5 countries (France, Germany, Italy, Spain and the…

DiabetesEuropeMarkets & MarketingPharmaceutical

F-Star and Merck Serono in up to 492 million-euro collaboration on novel targeted biologics


Austrian biotech firm F-Star GmbH has entered into a research, license and commercialization agreement…

BiotechnologyF-StarLicensingMerck KGaAMerck SeronoPharmaceuticalResearch

Draft guidance from UK's NICE recommends clinical trial for COPD drug Daxas


New draft guidance from the UK's drug watchdog the National Institute for Health and Clinical Excellence…

DaxasEuropeMerck & CoNycomedPharmaceuticalPricingRegulationRespiratory and Pulmonary

Teva and Alcobra ADHD candidate meets primary endpoint in Ph II


Israeli generics drug giant Teva Pharmaceutical Industries (Nasdaq: TEVA) and start-up drug developer…

AlcobraMetadoxineNeurologicalPharmaceuticalResearchTeva Pharmaceutical Industries

Alkermes shareholders vote in favor of merger with Elan Drug Technology


Shareholders of USA-based Alkermes (Nasdaq; ALKS) have voted to approve the previously-announced $960…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsPharmaceutical

Senior appointments at Novo Nordisk and Sucampo


The US unit of Danish insulin giant Novo Nordisk (NVO: N) has appointed Eddie Li, as vice president,…

ManagementNovo NordiskPharmaceuticalSucampo

TNF inhibitors used for rheumatoid arthritis associated with increased skin cancer risk


Biological agents used to treat rheumatoid arthritis seem to be associated with an increased risk of…


Global pharmacovigilance spending forecast to reach $15.46 billion by 2015


Spending on pharmacovigilance will reach a value of $15.46 billion by 2015, compared with just under…


Major global expansion of Rx-to-OTC switch forecast by 2016


There is a strong case that selected prescription (Rx) drugs today will gain over-the-counter (OTC) status…

GlobalMarkets & MarketingPharmaceutical

CimaVax-EGF, the first vaccine against lung cancer, debuts in Cuba


Following regulatory approval earlier this year, Cuban medical authorities have launched the world's…

CimaVax-EGFMarkets & MarketingOncologyPharmaceuticalVaccines

Irritable bowel syndrome drug market set to grow to $1.6 billion by 2018


The global irritable bowel syndrome (IBS) therapeutics market was valued at $655.8 million in 2010, and…

Gastro-intestinalsMarkets & MarketingPharmaceutical

Exec appointments at SkyePharma, Impax, Ariad and Regeneron


UK-based drug delivery specialist SkyePharma (LSE: SKP) has appointed Pierre Delavaud as executive vice…

Ariad PharmaceuticalsGenericsImpax LaboratoriesManagementPharmaceuticalRegeneronSkyepharma

Novo Nordisk extends free insulin and diabetes care program to India


Denmark’s Novo Nordisk (NVO: N), the world’s largest insulin maker, yesterday launched its…

Asia-PacificDiabetesMarkets & MarketingNovo NordiskPharmaceutical

Germany dedicates billions to fund health care research


Germany has allocated over 5.5 billion euros (nearly $8 billion) in federal grants to support health…


Sanofi sets 5% sales growth goal; views Genzyme synergies, patent losses and R&D


Christopher Viehbacher, chief executive of French drug major Sanofi (Euronext: SAN), says the company…


Disappointing FDA briefing papers on Bayer/J&J’s Xarelto


US Food and Drug Administration staffers posted a negative picture for German drug major Bayer (BAY:…

BayerCardio-vascularJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Takeda’s Mepact backed by UK’s NICE for osteosarcoma, after previous negative opinion


In a U-turn by the UK drug watchdog, in its latest appraisal, the National Institute for Health and Clinical…

EuropeMepactOncologyPharmaceuticalPricingRegulationTakeda Pharmaceuticals

ViroPharma's Buccolam gets EU approval for treatment of pediatric acute seizures


USA-based ViroPharma (Nasdaq: VPHM) said yesterday that the European Commission has granted a Centralized…


Novartis aims to become leading producer of innovative drugs in Russia


Swiss pharmaceutical major Novartis (NOVN: VX) plans to become a lead partner of the Russian government…

FinancialMarkets & MarketingNovartisPharmaceutical

6576 to 6600 of 6944 results

Back to top